The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio. (France 24) COVID-19 pandemic in mainland China, COVID-19 vaccination in mainland ChinaCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save